Hybrid Membrane-Derived Nanoparticles for Isoliquiritin Enhanced Glioma Therapy

Due to the obstruction and heterogeneity of the blood-brain barrier, the clinical treatment of glioma has been extremely difficult. Isoliquiritigenin (ISL) exhibits antitumor effects, but its low solubility and bioavailability limit its application potential. Herein, we established a nanoscale hybri...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Wenwan, Cao, Xia, Liu, Qi, Zhu, Qin, Liu, Kai, Deng, Tianwen, Yu, Qingtong, Deng, Wenwen, Yu, Jiangnan, Wang, Qilong, Xu, Ximing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506545/
https://www.ncbi.nlm.nih.gov/pubmed/36145280
http://dx.doi.org/10.3390/ph15091059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506545/
https://www.ncbi.nlm.nih.gov/pubmed/36145280
http://dx.doi.org/10.3390/ph15091059

Ejemplares similares